Roche Singapore celebrates 50 years - a joint journey in evolving Singapore’s healthcare system

• Roche Singapore began formal operations in 1973 and has grown significantly to become a local leader in the Lion City

• Today, Roche’s presence in Singapore spans pharmaceuticals and diagnostics, as well as two biologics manufacturing sites

• Deeply committed to Singapore’s healthcare system for 50 years, Roche looks forward to continuing this success story in the future

• Roche Singapore will launch a new Asia Pacific (APAC) healthcare innovation hub, bringing together public and private partners - this is the latest testament to Roche’s commitment to innovation for Singapore and the region

Roche today proudly commemorates its 50th anniversary of operations in Singapore. This milestone is being marked with a celebratory event attended by Mr. Ong Ye Kung, Minister for Health of Singapore and Dr. Thomas Schinecker, CEO of the Roche Group.

Roche Singapore started in a modest office on Shenton Way in 1973 and has grown into a local leader in diagnostics and innovative medicines across multiple disease areas. Today, Roche Singapore employs more than 1,000 people across its pharmaceuticals, diagnostics and manufacturing divisions. 

Focus on long-term partnerships

Looking ahead, long-term public-private partnerships (PPPs) will be a central focus for Roche Singapore - both deepening existing relationships and forging new ones. Tangible benefits have already been achieved with long-term PPPs such as the ARiSE Patient Support Programme and FlexCare collaborations with Singapore public healthcare institutions, and the partners are studying their future evolution. 

Roche also remains committed to PPPs in their earlier stages, such as the research partnership with the Singapore Translational Cancer Consortium to build a local clinico- genomic database for precision oncology. 

Supporting local health innovation

Innovation has and will be the driving force for Roche Singapore in the future. Singapore is already the APAC base for Startup Creasphere, Roche’s global digital health innovation accelerator, which has supported four Singapore-based startups since its inception in 2020.

Last year, Roche and the National Health Innovation Centre (NHIC) announced an open innovation partnership to explore collaboration opportunities for clinically and commercially impactful healthtech projects from an early stage.

It is also working with various APAC ecosystem stakeholders to co-develop In-Co Hub, a new APAC hub for healthcare innovation. In-Co Hub will serve as an open innovation platform for Roche to partner with government agencies, venture capitals, accelerators and startups to bring promising innovations to market. With Startup Creasphere and In-Co Hub, Roche aims to accelerate adoption and scaling of biomedical innovation across the APAC region.